CTOs on the Move

IARP Headquarters

www.iarp.org

 
IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iarp.org
  • 3540 Soquel Ave Ste A
    Santa Cruz, CA USA 95062
  • Phone: 831.464.4892

Executives

Name Title Contact Details

Similar Companies

Matheny Medical and Educational Center

Matheny Medical and Educational Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Peapack, NJ. To find more information about Matheny Medical and Educational Center, please visit www.matheny.org

Universal Health Services

Universal Health Services, Inc. (NYSE: UHS) is a Fortune 500 company based in King of Prussia, Pennsylvania. UHS owns and operates acute care hospitals, behavioral health centers, and ambulatory surgery centers in 37 states, Puerto Rico and the U.S. Virgin Islands. Universal Health Services, Inc. (UHS) is one of the largest hospital management companies in the United States. Through its subsidiaries, UHS operates 226 acute care hospitals, behavioral health facilities and ambulatory surgery centers. The company employs more than 60,000 people.

Sanomedics

Sanomedics International Holdings, Inc. (SIMH) manufactures and distributes innovative professional medical, as well as, home health diagnostic devices and products.

Willow Crest Hospital

It is the vision of Willow Crest hospital to be the provider of choice for patients, family members, and referral sources. We shall strive to exceed expectations of our customers in the provision of high quality, cost effective services.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.